BTG plc: Completion of the Acquisition of Protherics PLC
BTG plc announced that all the conditions to its recommended offer for Protherics PLC have been satisfied and the Acquisition has therefore been completed. Accordingly, 104,044,710 new BTG ordinary shares of 10 pence each issued in connection with the Acquisition were admitted to the Official List and to trading on the London Stock Exchange.
BTG confirms that Rolf Soderstrom, Finance Director of Protherics PLC, has joined the board of BTG as Chief Financial Officer and Christine Soden, the current Chief Financial Officer of BTG, has moved to the role of Chief Operating Officer.
“We are delighted to have completed this merger with Protherics, which gives us the platform to build a leading specialty pharmaceuticals business,” commented Louise Makin, BTG’s Chief Executive Officer. “Initial integration activities will focus on prioritising programmes in the development pipeline and rationalising operations to achieve the planned synergies and cost savings. We will provide an update on progress in due course.”
Other news from the department business & finance
